Clin2
NCT06488105Possibly a fitRecruiting

ER Heart Risk Check for Cholesterol Study

Lipid DisorderHypercholesterolemiaCardiovascular DiseasesAtherosclerosis

Treatments studied

Part of Heart & circulation, Hormones & metabolism clinical trials.

This trial tests a new way to check heart risk and start treatment for cholesterol in people coming to the emergency room with chest pain or possible heart attack. It aims to see if early risk assessment and treatment can prevent future heart problems.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
130 people
Ages
40 years to 75 years
Study type
Interventional

Who can take part

  • You are between 40 and 75 years old and currently being evaluated for possible heart attack symptoms.
  • Your 10-year risk of a heart-related event is 7.5% or higher, or you have diabetes, or you have had a previous heart attack, stroke, or artery disease.
  • You cannot be taking any cholesterol-lowering medication (statins, Zetia, PCSK9 inhibitors, etc.) at the start.
  • You must be able to return for a follow-up visit after 30 days.
  • You must not be pregnant, on dialysis, have liver cirrhosis, or have unstable vital signs (like low blood pressure or high heart rate).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06903442Recruiting
Helping ER chest pain patients understand heart risk

This study is testing a new way to talk with people about their heart health after they come to the Emergency Room with chest pain. It aims to help you understand your risk and what you can do to prevent future problems.

Edinburgh
NCT07615296Not yet recruiting
Ultra-low cholesterol targets for very high-risk heart disease

This study tests whether lowering cholesterol to very low levels (below 1.0 mmol/L) is more beneficial and safe than a slightly higher target (1.0–1.39 mmol/L) in patients with severe, recurrent heart or stroke events. You'll receive cholesterol-lowering medications and regular monitoring to see which target works best.

Beijing, Beijing Municipality
NCT07311941Recruiting
Rapid cholesterol lowering for heart disease patients

This study tests whether quickly increasing cholesterol-lowering medication can reduce the risk of another heart attack or stroke. It is for people who have heart disease from blocked arteries.

Shatin, New Terrritories
NCT07034690Recruiting· Phase 4
Better cholesterol control for high-risk patients

This study tests whether an educational program can help people with high cholesterol and heart disease get their LDL cholesterol levels lower. It involves watching online videos and working with your doctor to adjust treatments.

Abu Dhabi
NCT06738758Recruiting
Early intensive cholesterol-lowering study for acute coronary syndrome

This study tests whether starting strong cholesterol-lowering treatment early in the hospital can improve outcomes for people with acute coronary syndrome (a serious heart condition like a heart attack or unstable angina). It may help if you have high LDL cholesterol.

Beijing, Beijing Municipality
NCT06526013Recruiting
Cholesterol self-testing after a heart attack

This trial tests if people who recently had a heart attack can use a home cholesterol test to check if their LDL cholesterol is on target. The goal is to help you manage your cholesterol better and lower your risk of another heart problem.

Leipzig, Saxony

Hear when a new Lipid Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.